Current Size: 100%

Ludwig Boltzmann Institute for Hematology and Oncology

Workgroup LBI HO

The Ludwig Boltzmann Institute for Hematology and Oncology (LBI HO, formerly Ludwig Boltzmann Cluster Oncology (LBC ONC)), which focuses on tumor stem cell research, was initially established from the Ludwig Boltzmann Institute for Clinical Experimental Oncology at the Medical University of Vienna and the Ludwig Boltzmann Institute for Leukemia Research and Hematology at the Hanusch Hospital.

Austrian Society for Stem Cell Research founded

On March 20, 2018 the Austrian Society for Stem Cell Research (ASSCR.at) was founded, with the goal of connecting the most important stakeholders of national stem cell research, bundling research activities and exchange between science, patients and physicians.

Sanofi-Aventis-Award for two colleagues from LBI HO

Two highly talented researchers from the hematology department were honored by the Sanofi-Aventis-Award 2017. This award was given to Dr. Barbara Peter and Dr. Katharina Blatt from the Ludwig Boltzmann Institute for Hematology and Oncology (formerly Ludwig Boltzmann Cluster Oncology) coordinated by Prof. Valent, for two publications in renowned scientific journals.

LBI HO Contribution to the Blue Book of the WHO

The latest edition of the Blue Book of the WHO, titled the 'Classification of Tumours of Haematopoietic and Lymphoid Tissues', is now available. The basic concept of the classification of mastocytosis has in part been developed in Vienna.